---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-000518"
form_type: "8-K"
ticker: "ASBP"
cik: "0001847345"
company_name: "Aspire Biopharma Holdings, Inc."
filed_at: "2026-01-06T23:59:59+00:00"
generated_at: "2026-05-16T11:33:38.472389+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Aspire Biopharma converts ~$1.75M debt from PowerUp sponsors into common stock

## Summary
- Exchanged ~$1.75M debt for common stock at closing price less $0.01/share; holders can submit up to 4 exchange notices by Jan 31, 2026.
- Each exchange notice limited to 30% of outstanding balance; shares are freely tradeable without restrictive legends.
- Upon a financing over $3M, company may repay debt; holder can elect 25% of outstanding balance from proceeds.
- Exchange exempt under Section 3(a)(9) of Securities Act; debt originated from 2024 subscription agreements with PowerUp sponsors.

## SEC filing metadata
- accession: 0001493152-26-000518
- form_type: 8-K
- ticker: ASBP
- cik: 0001847345
- company_name: Aspire Biopharma Holdings, Inc.
- filed_at: 2026-01-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1847345/000149315226000518/0001493152-26-000518-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1847345/000149315226000518/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-000518
- JSON: https://secwatch.observer/filing/0001493152-26-000518.json
- Plain text: https://secwatch.observer/filing/0001493152-26-000518.txt

## Key facts
- Material Agreements
  Aspire Biopharma Holdings, Inc. entered into Exchange Agreements with certain holders of the Company’s debt valued at approximately $1.75 million (effective 2026-01-01).
  - Action: entry
  - Counterparty: certain holders of the Company’s debt
  - Value: approximately $1.75 million
  - Effective: 2026-01-01
  source text: On January 1, 2026, the Company entered into Exchange Agreements (the “Exchange Agreements”) with certain holders of the Company’s debt (the “Holders”) to exchange approximately $1.75 million in debt for shares (the “Exchange Shares’) of the Company’s common stock (the “Exchange”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1847345/000149315226000518/0001493152-26-000518-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.